Metabolic syndrome criteria: ready for clinical prime time or work in progress?

被引：10

作者：

Sattar, N

Forouhi, NG

机构：

[1] Univ Glasgow, Glasgow Royal Infirm, Div Cardiovasc & Med Sci, Sect Vasc Biochem, Glasgow G31 2ER, Lanark, Scotland

[2] MRC, Epidemiol Unit, Cambridge CB1 8RN, England

来源：

EUROPEAN HEART JOURNAL | 2005年 / 26卷 / 13期

关键词：

D O I：

10.1093/eurheartj/ehi296

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1249 / 1251

页数：3

共 14 条

[11] Insulin resistance and cardiovascular events with low HDL cholesterol - The Veterans Affairs HDL Intervention Trial (VA-HIT) [J].

Robins, SJ ;

Rubins, HB ;

Faas, FH ;

Schaefer, EJ ;

Elam, MB ;

Anderson, JW ;

Collins, D .

DIABETES CARE, 2003, 26 (05) :1513-1517

[12] Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study [J].

Sattar, N ;

Gaw, A ;

Scherbakova, O ;

Ford, I ;

O'Reilly, DS ;

Haffner, SM ;

Isles, C ;

Macfarlane, PW ;

Packard, CJ ;

Cobbe, SM ;

Shepherd, J .

CIRCULATION, 2003, 108 (04) :414-419

[13]

Scarpello JHB, 2003, DIABETES METAB, V29, pS36

[14] Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? [J].

Stern, MP ;

Williams, K ;

González-Villalpando, C ;

Hunt, KJ ;

Haffner, SM .

DIABETES CARE, 2004, 27 (11) :2676-2681

← 1 2 →